Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.87 |
| ▸ | CHAT | P28329 | 2/20 | 0.83 |
| ▸ | EP300 | Q09472 | 3/20 | 0.82 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.82 |
| ▸ | AURKA | O14965 | 2/20 | 0.82 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.82 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29424596 | 1.00 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL2757454 | 1.00 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL27830848 | 1.00 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Hexanoyl-Coa SCHEMBL21496009 | 0.98 | NAA50 (0.86) | NAA50CHATEP300KAT5AURKA | |
| Hexanoyl-Coa SCHEMBL60392 | 0.98 | NAA50 (0.86) | NAA50CHATEP300KAT5AURKA | |
| Hexanoyl-Coa SCHEMBL11940278 | 0.98 | NAA50 (0.86) | NAA50CHATEP300KAT5AURKA | |
| Octanoyl-Coa SCHEMBL24667663 | 0.98 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL1129961 | 0.98 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| Dodecanoyl-Coa SCHEMBL4309283 | 0.98 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL20970006 | 0.98 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4376826-A1 | AMINO ACID COMPOSITIONS AND METHODS FOR USE IN THE TREATMENT OF POST-ACUTE SEQUELAE OF COVID-19 | Axcella (Assignment for the benefit of Creditors), LLC (US) | 2024-06-05 | — | — | EP | claimed |
| WO-2024030909-A1 | BIOMARKERS OF AMINO ACID COMPOSITION TREATMENT RESPONSE IN LONG COVID | AXCELLA HEALTH INC. (US) | 2024-02-08 | — | — | WO | claimed |
| WO-2024026307-A1 | BIOMARKER FOR LONG COVID AND FATIGUE | AXCELLA HEALTH INC. (US) | 2024-02-01 | — | — | WO | claimed |
| US-20230038163-A1 | AMINO ACID COMPOSITIONS AND METHODS FOR THE TREATMENT OF POST-ACUTE SEQUELAE OF COVID-19 | AXCELLA (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC | 2023-02-09 | — | — | US | claimed |
| WO-2023009444-A1 | AMINO ACID COMPOSITIONS AND METHODS FOR USE IN THE TREATMENT OF POST-ACUTE SEQUELAE OF COVID-19 | AXCELLA HEALTH INC. (US) | 2023-02-02 | — | — | WO | claimed |
| CN-114364664-A | BCAT modulation | 伊卡根有限责任公司 | 2022-04-15 | — | — | CN | claimed |
| CN-110087647-A | Amino acid compositions and methods of treating liver diseases | 胺细拉健康公司 | 2019-08-02 | — | — | CN | claimed |
| EP-3510148-A1 | HIV CLINICAL PLAN | Excision Biotherapeutics, Inc. (US) | 2019-07-17 | — | — | EP | claimed |
| US-20190046486-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEURONAL INJURY | AXCELLA HEALTH INC. | 2019-02-14 | — | — | US | claimed |
| CN-108779477-A | The method for generating isobutene from 3- tiglyls-CoA | 环球生物能源公司 | 2018-11-09 | — | — | CN | claimed |
| WO-2018049372-A1 | HIV CLINICAL PLAN | EXCISION BIOTHERAPEUTICS INC (US) | 2018-03-15 | — | — | WO | claimed |
| CN-107075530-A | The method that isobutene is produced from 3 tiglyl CoA | 环球生物能源公司 | 2017-08-18 | — | — | CN | claimed |
| US-12460234-B2 | Synthesis of isoprenoids and derivatives | WILLIAM MARSH RICE UNIVERSITY (US) | 2025-11-04 | — | — | US | disclosed |
| US-20250270580-A1 | BCAT gene controlling drought tolerance of plant and uses thereof | LASEMILLA CO., LTD. (KR) | 2025-08-28 | — | — | US | disclosed |
| US-20250230473-A1 | TRANSGENIC STRAIN FOR PRODUCING 3-HYDROXY-3-METHYLBUTYRIC ACID AND PRODUCTION METHOD OF 3-HYDROXY-3-METHYLBUTYRIC ACID | NATIONAL YANG MING CHIAO TUNG UNIVERSITY (TW) | 2025-07-17 | — | — | US | disclosed |
| US-20240266069-A1 | COMPUTER ASSISTED METHOD FOR THE EVALUATION OF CARDIAC METABOLISM | Charité – Universitätsmedizin Berlin (DE) | 2024-08-08 | — | — | US | disclosed |
| EP-1098630-B1 | COMPOSITION FOR ENHANCING EPIDERMAL LIPID PRODUCTION | BIOMED RES AND TECHNOLOGIES IN (US) | 2005-09-21 | — | — | EP | disclosed |
| EP-1098630-A2 | COMPOSITION FOR ENHANCING EPIDERMAL LIPID PRODUCTION | Biomed Research and Technologies, Inc. (US) | 2001-05-16 | — | — | EP | disclosed |
| US-6149924-A | FOR TOPICAL APPLICATION | BIOMED RESEARCH & TECHNOLOGIES, INC. (US) | 2000-11-21 | — | — | US | disclosed |
| WO-2000004870-A2 | COMPOSITION FOR ENHANCING EPIDERMAL LIPID PRODUCTION | BIOMED RESEARCH AND TECHNOLOGIES, INC. (US) | 2000-02-03 | — | — | WO | disclosed |